Quantcast
Channel: Medical Research & Technology | Scoop.it
Viewing all articles
Browse latest Browse all 26

Vaccine Alum Adjuvant Path to Brain Documented: Study

$
0
0

Newly published research by Keele Conference scientists shows that aluminum adjuvant in vaccines transfers to the brain. They have documented the path from injection site to the brain, and that once in the brain, it persists. Newborns, the elderly, and people with a certain genetic variation are particularly at risk.

 

The use of nanomaterials in humans is not as contemporary as is recently portrayed. For decades, alum, a nanocrystalline compound formed of aluminum oxyhydroxide, has been the most commonly used adjuvant in vaccines.


Kate Drake's insight:
I agree with Sepp Hasslberger's insight:"Aluminium adjuvants in vaccines migrate to the brain and they persist there, wreaking destruction.

And here we are with vaccines being recommended particularly to the most vulnerable population groups - infants whose brain is developing, and elderly people who are at risk of Alzheimer's and similar degenerative conditions linked to aluminium.

Modern medicine!

Also relevant in this connection:https://www.youtube.com/watch?v=JKfbkeQyw84Vaccine Safety Conference - Dr. Christopher Exley on the systemic toxicity of aluminium adjuvants." How can the FDA and government bodies rugulate that vaccines with this element in it, is safe for it's people?! It's a true tragety.


Viewing all articles
Browse latest Browse all 26

Latest Images

Trending Articles





Latest Images